News
Third COVID booster benefits cancer patients
- Author:
- Jim Kling
For the first time, researchers have quantified the benefits of boosters for COVID-19 in cancer patients.
News
Stem cell therapy strikes out in progressive MS
- Author:
- Jim Kling
A retrospective study suggests no advantage of AHSCT over disease-modifying therapy in progressive MS.
News
More evidence for EBV’s role in MS
- Author:
- Jim Kling
Genetic sequencing of T-cell responses suggests the possibility of an ongoing immune response.
News
GFAP may complement NfL as MS biomarker
- Author:
- Jim Kling
GFAP is linked to progression while NfL is linked to inflammation.
News
Findings may be practice changing for early breast cancer patients
- Author:
- Jim Kling
A radiation boost to the tumor bed during whole breast irradiation was as safe and effective as delivering the boost sequentially.
News
NfL levels might presage MS disability
- Author:
- Jim Kling
A spike occurred about a year before clinical worsening.
News
ctDNA hints at esophageal cancer outcomes
- Author:
- Jim Kling
Reductions in ctDNA were associated with better progression-free and overall survival.
News
Radiotherapy shows benefit in difficult liver cancer cases
- Author:
- Jim Kling
SBRT combined with sorafenib led to a strong survival benefit versus sorafenib alone in a difficult to treat liver cancer.
News
Should McDonald criteria include optical nerve lesions?
- Author:
- Jim Kling
Researchers come out in favor, with a caveat against misdiagnoses.
News
High-efficacy therapies for MS: When and how to use them
- Author:
- Jim Kling
Experts make the case for use of high-efficacy therapies in MS.
News
In childhood sickle cell disease stroke prevention is key
- Author:
- Jim Kling
“Children with sickle cell disease have 100 times the risk of stroke as other children without sickle cell disease.”
News
Health care workers face unimaginable decisions in Ukraine
- Author:
- Jim Kling
From telemedicine to pediatric evaluations, international health care agencies are working to mitigate the effects of war.
News
Study affirms better breast cancer outcomes when chemo comes first
- Author:
- Jim Kling
Survival is better when high-risk breast cancer patients receive chemo first, followed by abemaciclib and estrogen therapy.
News
Psychiatric comorbidities in the pediatric neurology clinic
- Author:
- Jim Kling
Neurologists are in a unique position to help recognize and treat psychological comorbidities in their patients.
News
Durvalumab combinations show tentative promise in NSCLC
- Author:
- Jim Kling
Phase 2 study indicates improved survival and objective response rate when combined with other immunotherapies.